The model of apoE-/- mice, which develop dyslipidemia and atherosclerotic plaques spontaneously, is devoid of overwhelming metabolic and inflammatory disturbances caused by cholesterol overloading, and is more reliable for studies of mechanisms of the anti-atherosclerotic action of potential drugs [21]. The gene discussed is APOE; the disease is metabolic syndrome.